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INTRODUCTION
Cancer treatment and supportive care measures have greatly
improved the overall survival of pediatric patients with cancer. Cancer
related complications, such as life threatening infections and tumor
related compression of vital organs, can require prompt medical
evaluation [1–3]. Recognition of these complications may be delayed
in children related to diminished communication ability and different
pathophysiology, that can mask early signs of sepsis [4].
A systematic review of emergency department (ED) utilization
among adult cancer patients revealed a variety of cancer-treatment
or disease related presentations, including fever and neutropenia
(FN), infection, pain, fever and dyspnea. Over half of ED visits for
adult cancer patients resulted in admission [5]. Given an interest in
reducing these high admission rates, there are recent publications
exploring the safety of direct ED discharge for adult cancer patients
with FN [6]. To date, existing literature on pediatric patients with
cancer has predominantly focused on outcomes among hospitalized
patients [7,8] without an acknowledgement of the ED management
prior to admission.
The purpose of this investigation was to explore reasons
prompting ED visits among pediatric patients with cancer and risk
factors for admission to hospital from the ED.We hypothesized that
younger age and neutropenia would be independently associated
with higher rates of admission from the ED among pediatric
patients with cancer.
METHODS
Study Design and Setting
Pediatric patients with cancer were identified from an analysis of
pediatric EDencounters from2006 to 2010, using theHealthcare Cost
and Utilization Project’s (HCUP) Nationwide Emergency Depart-
ment Sample (NEDS), compiled by the Agency for Healthcare
Research and Quality [9]. The NEDS is a nationally representative
database that provides a 20% stratified probability sample of all
United States (U.S.) hospital-based EDs. The NEDS has been used in
several prior studies to examine ED utilization of pediatric patients
in the U.S. [10–12]. Data elements within the NEDS include
international classification of diseases, ninth revision, clinical
modification (ICD-9-CM) codes, patient demographic characteristics,
hospital characteristics, and inpatient data for ED admissions.
Discharge weights based on the sampling scheme were applied to
permit inference for a nationally representative population of ED
visits with pediatric cancer diagnoses. Each year of data contained
approximately 6 million pediatric (ages 0–19 years) ED encounters
that represented about 30 million weighted encounters in the U.S.
pediatric population per year. The analysis was based on de-identified
national data and therefore was considered exempt from institutional
review board approval by the University ofMichiganMedical School.
Identification of Sample
Pediatric patients, defined as those between ages 0–19 years,
were selected for analysis in order to allow U.S. population-
Background. Little is known about emergency department (ED)
use among pediatric patients with cancer. We explored reasons
prompting ED visits and factors associated with hospital admission.
Procedure. A retrospective cohort analysis of pediatric ED visits from
2006 to 2010 using the Nationwide Emergency Department Sample,
the largest all-payer database of United States ED visits. Pediatric
patients with cancer (ages 19 years) were identified using Clinical
Classification Software. Proportion of visits and disposition for the top
ten-ranking non-cancer diagnoses were determined. Weighted
multivariate logistic regression was performed to analyze factors
associated with admission versus discharge. Results. There were
294,289 ED visits by pediatric patients with cancer in the U.S. over
the study period. Fever and fever with neutropenia (FN) were the two
most common diagnoses, accounting for almost 20% of visits. Forty-
four percent of pediatric patients with cancer were admitted to the
same hospital, with admission rates up to 82% for FN. Risk factors for
admission were: FN (odds ratio (OR) 8.58; 95% confidence interval
(CI) 5.97–12.34); neutropenia alone (OR 7.28; 95% CI 5.08–10.43),
ages 0–4 years compared with 15–19 years (OR 1.19; 95% CI 1.08–
1.31) and highest median household income ZIP code (OR 1.27;
95%CI 1.08–1.49) comparedwith lowest. “Self-pay” visits had lower
odds of admission (OR 0.42; 95% CI 0.35–0.51) compared with
public payer. Conclusion. FN was the most common reason for ED
visits among pediatric patients with cancer and is the condition most
strongly associated with admission. Socioeconomic factors appear to
influence ED disposition for this population. Pediatr Blood Cancer
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adjusted estimates of ED utilization [13]. The pediatric cancer
patient subpopulation was identified using the HCUP Clinical
Classification Software (CCS) codes 11–45, which encompass all
types of malignancies. The CCS is a diagnosis and procedure
categorization scheme that collapses ICD-9-CM codes into a
smaller number of clinically meaningful categories. Demographic
and hospital characteristics were evaluated including: patient’s age,
sex, primary expected payer, median household income of the
patient’s ZIP code, hospital trauma designation, and hospital
teaching status. The disposition categories that were analyzed
included: discharged (patient treated and released from the ED),
admitted (patient admitted to same institution), transferred (patient
transferred to another short-term hospital), or died in the ED.
Variables
The reason prompting an ED visit was defined as the primary
ICD-9-CM discharge diagnosis associated with the visit, unless the
primary diagnosis was a cancer diagnosis (ICD-9-CM Codes 140-
239). In cases where a cancer diagnosis was the primary diagnosis
(18.4% of visits), the second listed ICD-9-CM diagnosis was
considered to be the reason prompting the ED visit. Cancer
diagnoses were excluded from our analysis in order to focus on
symptom or complication diagnoses among pediatric patients with
cancer who present to the ED.
A rank list of diagnoses was generated and visits were
categorized based on the top twenty diagnoses. For common
diagnoses to which multiple ICD-9-CM codes could map, general
categories were defined including fever (780.6, 780.60, 780.61),
neutropenia (288.0, 288.09), pneumonia (480–485), and upper
respiratory infection (460–465). Blood stream infections were
identified by the following ICD-9-CM codes: bacteremia (790.7),
septicemia (38), infection due to a vascular device, implant or graft
(996.62), or infection due to central venous line (999.31, 999.32).
The presence of FN has clinical importance, though it does not
have a unique ICD-9-CM code. Therefore, visits were assessed for
the combination of fever and neutropenia. Among patients with a
primary diagnosis of fever, all associated diagnoses were examined
for the presence of neutropenia and vice versa. Patients were
classified as having FN if their primary diagnosis was fever with
neutropenia in any of the diagnostic fields or primary diagnosis of
neutropenia with fever in any of the diagnostic fields.
Outcome
The primary outcome of interest was admitted to same
institution or discharged to home. Transfers out of the ED (3.7%)
were excluded from the regression because of the uncertainty about
the final disposition status of transferred patients due to lack of
patient level identifiers in the dataset. Patients who died in the ED
were also excluded (0.1%).
Data Analysis
In order to achieve nationally representative estimates, analyses
were weighted according to the Agency for Healthcare Research
and Quality-specified discharge variable (DISCWT). All results are
presented as weighted data unless otherwise specified. Descriptive
statistics were used to demonstrate the distribution of demographic
and hospital characteristics. The number of encounters for pediatric
patients with cancer were described as the rate of discharges per
100,000 U.S. children per year, using national census data for each
year [13]. The proportion of visits made by pediatric patients with
cancer and the disposition status was determined for the top 10
primary non-cancer diagnoses and for the FN variable.
A weighted multivariate logistic regression model was used to
estimate factors associated with admission for pediatric patients
with cancer and to account for clustering of patients by hospital.
Variables were included based on our defined model: patient’s age,
sex, primary expected payer, median household income for the
patient’s ZIP code, hospital trauma designation, hospital teaching
status, dichotomous variables for the presence or absence of each of
the top 10 most common primary diagnoses, and a dichotomous
variable for the presence of a hematologic malignancy. Due to the
limitations of administrative data which lack information regarding
disease stage and type or phase of therapy, a variable for hematologic
malignancy was included in our model. Previous studies have
documented an increased risk for serious infections among patients
with a hematologic malignancy as compared with non-hematologic
malignancies [14]. Statistical analyses were performed using
STATA version 12.0 (Stata Corp, College Station, TX).
RESULTS
Characteristics of the Study Population
There were 294,289 weighted ED visits for pediatric patients
with cancer ages 0–19 years over the 5 year study period, accounting
for approximately 0.2% of all pediatric ED visits in the U.S. The rate
of pediatric cancer-related ED visits in 2010 was 67 visits per
100,000 U.S. children ages 0–19 years. This was relatively
unchanged over the 5-year time span studied; ranging from the
lowest at 65 visits per 100,000 U.S. children ages 0–19 years in 2006
to the highest at 78 visits per 100,000 in 2008. Baseline demographic
characteristics of pediatric patients with cancer presenting to the ED
are described in Table I. Acute lymphoblastic leukemia (ALL) was
the most common cancer diagnosis (25.9%) among pediatric
patients with cancer who visited the ED. The distribution of the ten
most common types of cancer among pediatric ED visits is
demonstrated in Table II. Overall, 51.9% of pediatric patients with
cancer were evaluated in the ED and discharged to home, 43.6%
were admitted to the same institution, and 3.7% were transferred to
another short-term hospital. Only 390 (0.1%) of pediatric patients
with cancer died in the ED.
The 10 most common reasons prompting an ED visit for
pediatric patients with cancer are listed in Table III. Together these
10 diagnoses accounted for more than one-third of all non-cancer
primary diagnoses for ED visits by pediatric patients with cancer.
The primary diagnoses of fever or FN were the reason for almost
one in five ED visits; this finding was consistent across all 5 years.
There was variation in ED disposition across diagnoses.
Pediatric patients with cancer were admitted, the majority of the
time, when they presented with a primary diagnosis of fever and
neutropenia (82.3%), neutropenia only (80.1%), bloodstream
infections (74.7%), or pneumonia (67.8%). The lowest ED
admission rates were observed for visits with a primary diagnosis
of headache (10.6%) or fever alone (17.3%). The average transfer
rate for a pediatric cancer patient was 3.7%. The highest rates of
transfer were for seizures (9.9%), fever and neutropenia (6.5%), and
neutropenia only (6.2%).
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Factors Affecting Admission Among Pediatric Patients
With Cancer
In a multivariate analysis, factors associated with significantly
increased odds of admission included being between the ages of 0–
4 years (OR 1.19, 95% CI 1.08–1.31) as compared with those
between the ages of 15–19 years, having a median household
income in the highest income quartile (OR 1.27, 95%CI 1.08–1.49)
compared with the lowest quartile, and presenting to a metropolitan
teaching hospital (OR 3.72, 95% CI 2.58–5.48) compared with
metropolitan non-teaching hospital, as listed in Table IV. There
were increased odds of admission for those presenting with the
following primary diagnoses: fever and neutropenia (OR 8.58, 95%
CI 5.97–12.34), neutropenia only (OR 7.28, 95% CI 5.08–10.43),
pneumonia (OR 3.89, 95%CI 3.39–4.46), or dehydration (OR 1.84,
95%CI 1.52–2.23). Thosewhose primary payer was labeled as self-
pay were statistically less likely to be admitted (OR 0.42, 95% CI
0.35–0.51) as compared with public payers.
DISCUSSION
In this study, using administrative data, we found that fever and
FN are among the most common reasons for presentation to the ED.
Consistent with our hypothesis, we found that younger age (0–4
years) and having a diagnosis of FN or neutropenia were factors
associated with increased rate of admission from the ED. Our
results provide important insight into reasons behind ED visits for
pediatric patients with cancer and may help in resource planning.
Differences in ED admission rates across the wide range of reasons
for ED visits cannot be fully explained with hospital administrative
data available to our group, but may reflect processes around cancer
care within individual institutions. Studies including patient-level
factors, such as disease stage and treatment regimen, will be needed
to determine if this variation is warranted. Understanding whether
TABLE II. Pediatric Cancer Patient ED Visits—by Cancer Type,
2006–2010
Type of Cancer N Proportion (%)
Acute lymphoblastic leukemia 76,226 25.9
Central nervous system tumor 23,842 8.1
Acute myelogenous leukemia 22,105 7.5
Bone tumor 11,551 3.9
Neuroblastoma 7,760 2.6
Hodgkin lymphoma 7,491 2.5
Soft tissue sarcoma 7,075 2.4
Wilms tumor 6,959 2.4
Non-hodgkin lymphoma 4,636 1.6
Hepatic tumor 3,113 1.1
TABLE I. Characteristics of Pediatric Cancer Patients Presenting to the Emergency Department, Overall and by Disposition Status—
United States, 2006–2010
Overall (%)
Admitted Discharged
P-valueProportion (95% CI) Proportion (95% CI)
Patient characteristics
Gender <0.001
Female 47.6 46.6 (45.6–47.5) 48.7 (47.4–50.0)
Age <0.001
0–4 years 28.6 32.7 (31.3–34.1) 25.0 (23.5–26.5)
5–9 years 22.7 22.2 (21.2–23.3) 23.0 (21.6–24.5)
10–14 years 18.5 18.3 (17.3–19.2) 18.5 (17.6–19.4)
15–19 years 30.3 26.8 (24.7–28.9) 33.4 (30.6–36.2)
Primary payer <0.001
Public 43.0 43.5 (39.2–47.9) 42.4 (37.8–47.0)
Private 47.2 48.3 (44.4–52.2) 46.2 (42.7–49.7)
Self-pay 4.2 2.2 (1.8–2.7) 5.7 (4.8–6.7)
Other 5.7 5.9 (3.8–8.0) 5.6 (3.7–7.5)
Median household income per zip code <0.001
1st quartile 24.6 23.3 (20.3–26.2) 25.8 (22.8–28.8)
2nd quartile 26.6 25.2 (23.1–27.4) 27.8 (26.1–29.4)
3rd quartile 24.7 25.8 (24.0–27.6) 24.3 (22.5–26.0)
4th quartile 22.9 25.7 (21.9–29.5) 21.0 (18.6–23.4)
Hospital characteristics
Trauma level <0.001
Level 1 32.1 42.9 (31.4–54.5) 25.1 (17.1–33.1)
Level 2 8.0 8.0 (3.4–12.7) 8.0 (4.6–11.4)
Level 3 5.2 2.6 (0.4–4.9) 6.4 (4.5–8.4)
Non-trauma 32.5 21.0 (13.7–28.2) 39.5 (32.2–46.9)
Teaching Status <0.001
Metro, non-teaching 19.7 9.9 (5.2–14.6) 25.5 (20.6–30.3)
Metro, teaching 71.8 87.9 (83.0–92.8) 62.3 (55.4–69.3)
Non-metro 8.5 2.3 (1.6–2.9) 12.2 (9.8–14.6)
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some of these admissions may be preventable will require further
research and has important implications for quality of care.
In addition to variations associated with the reason for ED visits,
we found that pediatric patients with cancer presenting to a
metropolitan teaching hospital ED had higher odds of admission
and patients presenting to non-metropolitan hospitals had lower
odds of admission than patients presenting to metropolitan non-
teaching. Previous literature has demonstrated that there are no
significant differences in outcomes, including mortality, between
teaching and nonteaching health care systems [15]. The patients
presenting at metropolitan teaching hospital EDs could be expected
to have higher acuity given that these centers are typically where
more intensive therapies, such as bonemarrow transplants and early
phase clinical trials are performed, and where many pediatric
patients with cancer receive their care. Higher rates of ED
admission at metropolitan teaching hospitals may be the result of
clinical management protocols in the ED or by subspecialty
services, particularly with the inclusion of physician trainees. The
influence of patient acuity, location of care, and subspecialty
services on admission decision deserves future study.
Our results also indicate that socioeconomic factors may have a
significant impact on admission with lower odds of admission
among those designated as “Self Pay” in the dataset and higher odds
of admission among patients from highest quartile median
household income per ZIP code. What is not clear is whether
patients of higher socioeconomic status are being admitted more
often than is clinically necessary or if these children present to the
EDwithmore severe illness and admission is required. Alternatively
patients of lower means may be admitted too infrequently or these
children present to the ED earlier in the course of illness when
outpatient management is possible. These findings lead to questions
about the impact of available resources at home and family
preference on rates of admission. There is also potential for
providers’ decisions to admit to be influenced by families’
socioeconomic status. While we observed differences in rates of
admission along socioeconomic lines, we cannot assess clinical
outcomes for these patients whowere admitted compared with those
who were not admitted with NEDS. This is an essential area to
investigate in order to ensure equitable care is provided to children
with ED visits for cancer or treatment-related complications.
ED admission decisions may also be related to more practical
issues such as traveling distance to the hospital system where the
child primarily receives their cancer care. Pediatric patients with
cancer in this study had inter-hospital transfer rates as high as 9.9%,
with an overall rate (3.7%) almost seven times higher than the
general pediatric population [16]. This highlights that pediatric
patients with cancer may not be initially presenting to the hospital
systemwhere the child primary receives their cancer care. Thus, the
care of pediatric patients with cancer requires high levels of
pediatric medical expertise and involvement of many disciplines
and health care facilities to coordinate care. Qualitative research is
needed to understand how patients and their families consider
finances and travel related to the care of pediatric patients with
cancer in ED settings as well as how health care providers can
communicate most effectively across disciplines and institutions to
delivery coordinated care to pediatric patients with cancer.
Due to the clinical importance of FN as a potentially life-
threatening complication of chemotherapy [3,17], the high
frequency with which pediatric patients with cancer seek ED
care for fever or FN, and published guidelines that make a weak
recommendation for pediatric outpatient management of FN if
appropriate resources are available to support this model of
care [18], this is an important area for future research. Our results
show discharge from the ED for FN happens only 11% of the time.
The implementation of pediatric practices for outpatient manage-
ment of FN is not well understood. Previous evidence has
demonstrated several key principles for optimal outpatient care.
The role of the ED to provide prompt evaluation and treatment has
been shown to improve outcomes with decreased need for
resuscitation measures and decreased mortality [19]. After the
initial ED triage and treatment, there is evidence that a subset of
patients at lower risk of infectious complications can be safely and
effectively managed in the outpatient setting [20,21]. A survey of
parental and health care provider preferences for the treatment of
FN among lower risk pediatric patients revealed that the majority
preferred outpatient therapy and that the perceived impact of
admission on health-related quality of life appears to be complex
and multifactorial [22]. In a decision-analytic model performed by
Teuffel et al, inpatient therapy for FN could not be justified on the
basis of safety and efficacy or patient/parent preferences [23].
TABLE III. Top Reasons Prompting ED Visits Among Pediatric Cancer Patients—Rank and Disposition Status, 2006–2010
Ranka Diagnosis N (%)
Disposition Status (%)
Admitted to
same hospital
Transferred to
another facility
Discharged
to home
1 Fever only 33,356 (11.3) 17.3 4.4 77.3
2 Febrile neutropenia 23,120 (7.9) 82.3 6.5 11.0
3 Bloodstream infection 12,768 (4.3) 74.7 2.8 22.4
4 Upper respiratory infection 8,277 (2.8) 21.5 0.5 77.5
5 Pneumonia 7,463 (2.5) 67.8 5.0 26.8
6 Neutropenia only 6,428 (2.2) 80.1 6.2 12.8
7 Headache 6,420 (2.2) 10.6 5.4 83.3
8 Seizure 4,395 (1.5) 40.9 9.9 48.5
9 Urinary tract infection 3,818 (1.3) 35.1 1.8 62.0
10 Dehydration 3,790 (1.3) 56.7 3.3 39.4
aRank list based off of combined 5 years.
Pediatr Blood Cancer DOI 10.1002/pbc
Pediatric Cancer Patient ED Usage 493
Therefore, multi-centered collaborations with an appreciation for
differences in institutional resources and involving emergency care
providers, oncologists, and primary care providers as well as
patients/families will ultimately be required to develop a
framework to facilitate outpatient management of FN for a subset
of patients at low risk of serious infections [18,24].
Our study has several important limitations. We narrowed our
evaluation to include only a single diagnostic code per patient
because this allowed for a framework to analyze the effect of the
reason for ED presentation on the odds of admission. This approach
does not take into account the fact that ED visits may be driven by
multiple symptoms or complications of cancer or cancer treatment.
Due to the nature of administrative databases, the discharge
diagnosis was utilized to define the reason for ED visit, but this is
not necessarily equivalent to the chief complaint at ED presentation.
The first diagnosis listed, other than cancer, was assumed to be the
symptom or complication that prompted the ED encounter by the
patient, but may vary by hospital based on the method to assign
the order of the ICD-9-CM codes. The order of ICD-9-CM codes
may be determined by the ED clinicians, inpatient providers
for admitted patients, or billers, depending on hospital coding
practices, and this may result in an overestimation or underestima-
tion of the number of patients presenting with certain symptoms.
Conversely, the absence of the diagnostic code does not necessarily
guarantee the lack of the symptom. Most importantly, FN holds
high clinical significance, but is not a single diagnostic code and
was conferred by the presence of both ICD-9-CM codes for fever
and neutropenia. It is likely that this was an underestimation of
patients with FN since those with “neutropenia only” had very
similar disposition patterns and odds of admission. Administrative
databases do not hold detailed information regarding the patients’
cancer staging, therapy regimens, vital signs or laboratory values,
which are all important factors in the decision making regarding
admission for a patient experiencing FN [14,18]. Lastly, counts of
visits may be overestimated because patients who were transferred
to another institution providing data to HCUP, the single patient ED
visit may have produced two encounters within the NEDS.
However, our report has several strengths. This study provides a
baseline evaluation of the ED utilization of pediatric patients with
cancer across the United States. Our data are highly generalizable
given the nature of the data source. Several key areas have been
highlighted for future investigation and intervention to improve the
care of this unique population. In time, longitudinal analyses of the
multi-institutional or national databases may allow for assessment
of ED utilization among pediatric patients with cancer in relation to
changes in clinical practice guidelines and evidence based practices
on an institutional or national level. While the level of detailed
information is typically not available in administrative data and
thus, our study demonstrates the utility of this type of research and
underscores the importance of pursuing innovative approaches to
data collection.
CONCLUSION
In conclusion, we found that fever and FN are among the most
common reasons for presentation to the ED for pediatric patients
with cancer. Factors associated with increased rate of admission
from the ED included younger age (0–4 years), median household
income in the highest quartile, and having a diagnosis of FN or
neutropenia. Important areas for future research include determin-
ing whether some of these admissions are preventable and
developing mechanisms to reduce admission rates for pediatric
patients with cancer.
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